BioValuation Advisors regularly publishes in media, academic and industry journals on topics such as valuation, licensing, corporate finance, mergers and acquisitions, venture capital, hedge funds, IPOs, investing and industry trends.
BioValuation Advisors understands itself as a think tank that challenges conventional thinking and bring new perspectives to the research frontiers. We regularly publish new insights and concepts in leading academic and industry journals.
Recent publications:
- Initial public offerings, subscription precommitments and venture capital participation. Journal of Corporate Finance 50, 650-668. Link
- Biomarker of quality? Venture-backed biotech IPOs and insider participation. Journal of Applied Corporate Finance 30(1), 78-88. Link
- Biotech venture investments in public equities and performance. Journal of Commercial Biotechnology 22(4), 39-52. Link
- Leaving money on the table in venture-backed biotechnology IPOs. Journal of Commercial Biotechnology 22(4), 27-38. Link
Working papers:
- Is there a winner’s curse in the biopharmaceutical industry?
- Corporate takeovers, sales procedures and alliances
- Security price behavior around regulatory decisions. Link
- Short- and long-horizon contrarian and momentum investing strategies around R&D announcements: An empirical investigation into biotechnology firms. Link
- Forecasting sales of new drugs: Understanding the drivers of value creation for biopharmaceuticals around the time of drug launch